Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Application of nicotinamide mononucleotide containing composition to ageing resisting drugs/health-care products

A single nucleotide and composition technology is applied in the directions of food ingredients containing natural extracts, medical preparations containing active ingredients, applications, etc., which can solve the problem of difficulty in taking into account the anti-aging effect of product quality stability and other problems, and improve the oxidation of the body. Stress response, good anti-aging, structurally stable effects

Inactive Publication Date: 2019-09-17
HOBOOMLIFE BIO TECH SHENZHEN CO LTD
View PDF0 Cites 16 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] In view of this, the present invention provides the application of the composition containing nicotinamide mononucleotide in anti-aging medicines / health care products, which is used to solve the problems in the prior art that anti-aging products have a good anti-aging effect and are harmful to the human body. Technical defects without hazards and stable product quality

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of nicotinamide mononucleotide containing composition to ageing resisting drugs/health-care products
  • Application of nicotinamide mononucleotide containing composition to ageing resisting drugs/health-care products
  • Application of nicotinamide mononucleotide containing composition to ageing resisting drugs/health-care products

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0037]This embodiment is a specific embodiment for preparing product 1.

[0038] Niacinamide mononucleotide, astragalus, ginseng, ginsenoside Rb1, coenzyme Q10, puerarin, Eucommia leaves and Huang Mao polysaccharide were dried separately, passed through a 60-80 mesh sieve, and mixed evenly to obtain the first product;

[0039] After the auxiliary materials are dried, mix them evenly, and pass through a 60-80 mesh sieve to obtain the second product; in this embodiment, the auxiliary materials are mannitol.

[0040] After the first product and the second product are dissolved in water, stir for the first time at 25-40°C, heat up after stirring evenly, then stir for the second time at 50°C, and after stirring for 1 hour, the preparation is tablet product 1; In the examples, the formulation process used is a conventional formulation process well known to those skilled in the art, and will not be repeated here.

[0041] In this example, in the first product, the dosage of each raw...

Embodiment 2

[0043] This embodiment is a specific embodiment for preparing product 2.

[0044] Niacinamide mononucleotide, astragalus, ginseng, ginsenoside Rb1, coenzyme Q10, puerarin, Eucommia leaves and Huang Mao polysaccharide were dried separately, passed through a 60-80 mesh sieve, and mixed evenly to obtain the first product;

[0045] After the auxiliary materials are dried, mix them evenly, and pass through a 60-80 mesh sieve to obtain the second product; in this embodiment, the auxiliary materials are microcrystalline cellulose.

[0046] After the first product and the second product are dissolved in water, stir for the first time at 25-40°C, heat up after stirring evenly, then stir for the second time at 50°C, and after stirring for 1 hour, the product 2 is obtained as a pill; this implementation In the example, the formulation process used is a conventional formulation process well known to those skilled in the art, and will not be repeated here.

[0047] In this example, in the...

Embodiment 3

[0049] This embodiment is a specific embodiment for preparing product 3.

[0050] Niacinamide mononucleotide, astragalus, ginseng, ginsenoside Rb1, coenzyme Q10, puerarin, Eucommia leaves and Huang Mao polysaccharide were dried separately, passed through a 60-80 mesh sieve, and mixed evenly to obtain the first product;

[0051] After the auxiliary materials are dried, mix them evenly, and pass through a 60-80 mesh sieve to obtain the second product; in this embodiment, the auxiliary materials are magnesium stearate.

[0052] After the first product and the second product are dissolved in water, stir for the first time at 25-40°C, heat up after stirring evenly, then stir for the second time at 50°C, and after stirring for 1 hour, the preparation is granule product 3; In the examples, the formulation process used is a conventional formulation process well known to those skilled in the art, and will not be repeated here.

[0053] In this example, in the first product, the feedin...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
particle size (mesh)aaaaaaaaaa
Login to View More

Abstract

The invention belongs to the fields of research and development of drugs and health-care products, particularly relates to an application of a nicotinamide mononucleotide containing composition to ageing resisting drugs / health-care products, provides a composition, further provides a preparation method of the composition, and further provides the composition or the application of the product prepared by the preparation method to ageing resisting drugs / health-care products. NMN can achieve the effects of activating organism energy metabolism and improving an organism oxidation stress reaction, and besides, through cooperation with synergism of other components, favorable effect of resisting ageing can be achieved; and the components in the composition are stable in structure. The prepared product is not liable to deteriorate or damage, and besides, the components are safe. The product basically has no poor reaction on human bodies. The composition solves the technical problems that in the prior art, the ageing resisting products do not have favorable ageing resisting effect, are free from damage to human bodies, and are stable in product quality.

Description

technical field [0001] The invention belongs to the field of research and development of medicines and health products, and in particular relates to the application of a composition containing nicotinamide mononucleotide in anti-aging medicines / health products. Background technique [0002] With the continuous improvement of people's living standards, people's desire to pursue health and longevity is becoming stronger and stronger. However, aging is an inevitable law in any life process and a biological law that does not depend on human will. However, it is possible to delay the aging speed and make people's lifespan reach the maximum lifespan endowed by nature. So far, there have been hundreds of theories and hypotheses about the mechanism of aging, such as free radical theory, immune function degeneration theory, neuroendocrine theory, protein synthesis error accumulation theory, etc., as well as gene regulation based on molecular and gene levels in recent years. theory, ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/481A61P39/06A23L33/125A23L33/105A23L33/10A61K31/122A61K31/352A61K31/704A61K31/706A61K31/715
CPCA23V2002/00A61K31/122A61K31/352A61K31/704A61K31/706A61K31/715A61K36/258A61K36/46A61K36/481A23L33/10A23L33/105A23L33/125A61P39/06A61K2300/00A23V2200/302A23V2250/21A23V2250/2116A23V2250/51A23V2250/2124
Inventor 陈建生张波
Owner HOBOOMLIFE BIO TECH SHENZHEN CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com